PROWESS Sepsis Study Group. Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis - Dhainaut, JF; Yan, SB; Margolis, BD (Thromb Haemost, 2003)
et al.